Park Avenue Securities LLC Novo Cure LTD Transaction History

Park Avenue Securities LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Apr 08, 2022	SELL	$75.08 - $121.99 $129,663 - $210,676	-1,727 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$116.17 - $194.55 $76,439 - $128,013	658 Added 61.55%	1,727 $201,000
Q2 2021 Aug 05, 2021	BUY	$130.4 - $225.58 $139,397 - $241,145	1,069 New	1,069 $237,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.12B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.